Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

Novo Nordisk expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human data and artificial intelligence. The deal extends ...

Korea University College of Medicine (Dean: Pyun Sung-Bom) hosted a forum titled "Advancing Healthcare through Innovations in Data and AI in Clinical Informatics and Natural Language Processing" in ...

Selected preclinical small molecule candidates will now be tested through the Quris-AI platform prior to initiating clinical trials. This follows a successful two-year validation study with Merck KGaA ...

Rigetti offers full-stack quantum-classical computing. RGTI's advancements promise significant growth and reduced error rates ...

Blueprint Medicines' Ayvakit shows strong revenue growth, projected to reach over $2 billion in peak sales. Read my analysis ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

A line-up of experts across academia, pharma, and healthcare came together to discuss the impact and challenges of ...